By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Health Canada 

A.L. 0904A

Ottawa    K1A 0K9  Canada
Phone: 613-957-2991 Fax: 613-941-5366



Company News
BioDelivery (BDSI) Announces Health Canada Approval Of BELBUCA 6/23/2017 6:59:28 AM
Sommetrics Receives Health Canada Approval To Market New Sleep Apnea Therapy 6/21/2017 8:38:19 AM
Pfizer (PFE) Receives Expanded Health Canada Approval For IBRANCE In HR+, HER2- Metastatic Breast Cancer 6/21/2017 6:22:22 AM
Horizon Pharma (HZNP) Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis 6/19/2017 8:34:27 AM
Medtronic (MDT) SureTune3 Receives Health Canada Licence For Deep Brain Stimulation Therapy 6/6/2017 10:53:47 AM
Medtronic (MDT) Suretune3 Receives Health Canada License For Deep Brain Stimulation Therapy 6/6/2017 10:15:59 AM
Novoteris, LLC Receives FDA And Health Canada Clearance To Start A Phase II Clinical Trial Of Its Thiolanox Nitric Oxide For The Treatment Of Cystic Fibrosis 6/5/2017 7:43:51 AM
Health Canada Has Not Found Conclusive Evidence That Mefloquine Can Cause Long-Lasting And Permanent Neurological And Psychiatric Adverse Events 6/2/2017 6:58:48 AM
Health Canada Release: Advisory - Multiple Unauthorized L-Tryptophan And Lithium Orotate Products Sold On Amazon.Ca May Pose Serious Health Risks 5/31/2017 9:04:22 AM
Resverlogix (RVX.TO) Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone 5/30/2017 6:12:38 AM